All stocks Β· SHELTER
SP

SHELTER PHARMA LIMITED

SHELTER BSE Drug Manufacturers - Specialty & Generic Healthcare

Shelter Pharma Limited manufactures and sells pharmaceutical products for human and animals in India. The company offers tablets, ointments, syrups, capsules, and oil for human health care; and mineral mixture for veter…

ISIN INE013V01011
Listed β€”
Quarters tracked β€”
Filings 7 docs

About

Shelter Pharma Limited manufactures and sells pharmaceutical products for human and animals in India. The company offers tablets, ointments, syrups, capsules, and oil for human health care; and mineral mixture for veterinary health care. It also provides OTC and ethical products. The company sells its products through distribution network, as well as exports its products. Shelter Pharma Limited was founded in 1965 and is based in Ahmedabad, India.

Quarterly Results

No quarterly results synced yet for this stock.

Data is backfilled from screener.in β€” check back soon.

Profit & Loss

Annual Β· Rs. Crores
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017Mar 2016
Sales 73.1350.6439.9336.1530.0622.4830.0729.9528.09
Expenses 60.4140.5731.1428.0027.0122.2929.8330.6527.94
Operating Profit 12.7210.078.798.153.050.190.24-0.700.15
OPM % 17.3919.8922.0122.5410.150.850.80-2.340.53
Other Income 0.020.010.00-0.970.000.010.010.830.00
Interest 0.110.130.260.030.080.020.010.000.00
Depreciation 0.410.270.250.160.170.120.130.070.10
Profit before tax 12.229.688.286.992.800.060.110.060.05
Tax % 26.1925.2125.1225.4626.7933.3327.2716.6720.00
Net Profit 9.037.246.205.212.060.040.080.050.05
EPS in Rs 5.446.265.366.7342.560.831.761.101.10
Dividend Payout % 0.000.000.000.000.000.000.000.000.00

Balance Sheet

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017Mar 2016
Equity Capital 16.6111.5611.567.740.480.480.450.450.45
Reserves 60.0231.1624.266.818.326.636.537.327.31
Borrowings 0.801.040.581.780.130.000.240.112.07
Other Liabilities 6.804.581.515.123.913.093.413.761.73
Total Liabilities 84.2348.3437.9121.4512.8410.2010.6311.6411.56
Fixed Assets 7.146.644.262.521.451.571.772.712.61
CWIP 0.000.000.000.000.550.000.000.110.14
Investments 0.680.000.000.000.680.680.680.000.00
Other Assets 76.4141.7033.6518.9310.167.958.188.828.81
Total Assets 84.2348.3437.9121.4512.8410.2010.6311.6411.56

Cash Flows

Annual Β· Rs. Crores β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017
Cash from Operating Activity -12.485.48-1.960.000.52-0.28-0.270.00
Cash from Investing Activity -14.55-7.13-4.430.11-0.850.030.290.00
Cash from Financing Activity 24.690.0311.010.210.060.480.000.00
Net Cash Flow -2.34-1.624.610.33-0.270.230.020.00
Free Cash Flow -14.072.83-2.810.00-0.08-0.29-0.320.00
CFO/OP % -73.0079.00-5.000.0017.00-147.00-112.000.00

Ratios

Annual Β· Days / % β€” latest first
Metric Mar 2026Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020Mar 2017Mar 2016
Debtor Days 58.9568.2680.9082.6919.5512.347.4014.1412.99
Inventory Days 160.53127.15125.33110.6880.0669.4155.5949.6761.39
Days Payable 8.2112.328.966.544.525.353.352.162.49
Cash Conversion Cycle 211.26183.09197.26186.8495.0976.4059.6461.6571.89
Working Capital Days 234.43181.85212.07121.5771.6474.8554.1459.5991.35
ROCE % 20.3524.4832.3963.2635.911.12β€”0.68β€”

Shareholding Pattern

% holding β€” latest first
Holder May 2026 Mar 2026 Nov 2025 Sep 2025 Mar 2025 Sep 2024 Mar 2024 Sep 2023
Promoters 44.38 44.99 47.19 52.32 52.32 54.97 56.89 56.89
Public 55.61 55.00 52.82 47.68 47.68 45.03 43.12 43.11
No. of Shareholders 1,089 1,060 1,093 1,094 1,153 1,119 868 836

Corporate Actions

2 records
ActionEx DateRecord DateRatioAmount (β‚Ή)Notes
Dividend 23 Sep 2025 23 Sep 2025 β€” 0.35
Dividend 23 Sep 2024 β€” β€” 0.33

Announcements

5 filings